$TECH (BIO-TECHNE) — 8-K: Bio-Techne declares $0.08 quarterly dividend, contingent on Merck KGaA deal not closing by November 13

Bio-Techne's Board declared a quarterly dividend of $0.08 per share for the quarter ended September 30, 2026, payable November 23, 2026 to shareholders of record at the close of business on November 13, 2026. The dividend is conditioned on the company's previously announced transaction with Merck KGaA not having closed on or before the record date. Bio-Techne generated over $1.2 billion in net sales in fiscal 2026.

Bio-Techne's Board declared a quarterly dividend of $0.08 per share for the quarter ended September 30, 2026, payable November 23, 2026 to shareholders of record at the close of business on November 1